MedPath

DARIANTE 4 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG

DARIANTE 4 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG

Commercialized
Register Number

89092

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Oct 17, 2023

Dosage Form

PARCHE TRANSDÉRMICO

Route: VÍA TRANSDÉRMICA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89092
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

ROTIGOTINAActive
Quantity: 7,36 mg/24 h
Name: ROTIGOTINA

ATC CLASSIFICATION (3)

N04B
N04BC
N04BC09

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.